Is the six-minute walk test correlated with disease control and quality of life in children with asthma?
dc.contributor.author | Yüksel H. | |
dc.contributor.author | Yilmaz Ö. | |
dc.contributor.author | Gökşen B. | |
dc.contributor.author | Üstün S. | |
dc.contributor.author | Söǧüt A. | |
dc.date.accessioned | 2024-07-22T08:19:15Z | |
dc.date.available | 2024-07-22T08:19:15Z | |
dc.date.issued | 2012 | |
dc.description.abstract | Aim: To evaluate the changes in a 6-min walk test (6MWT) and quality of life (QoL) before and after asthma control is achieved in children. A 6MWT is used in the determination of disease severity in many chronic childhood diseases. Materials and methods: Thirty-six asthmatic children, aged 6 to 15 years, were enrolled before asthma control was achieved. Disease severity parameters during the previous 3 months were recorded. All of the children completed an asthma control questionnaire (ACQ) and received a symptom score; a 6MWT was performed during enrollment and 1 month later, when asthma control was achieved. Results: The initial and follow-up mean 6MWT distances were 500.2 ± 139.1 and 577.8 ± 147.9 m, respectively (P < 0.001). The 6MWT distances and ACQ scores were significantly correlated initially (rho = -0.35, P = 0.04). The 6MWT distance was not correlated with clinical parameters (P > 0.05 for all). The initial ACQ score was significantly correlated with the symptom score and duration of asthma (rho = 0.62 vs. rho = -0.37). Conclusion: A 6MWT may be used in the functional assessment of children with uncontrolled asthma; it correlates with ACQ scores. The absence of a correlation between the 6MWT and patient-reported symptom severity or other clinical parameters may indicate the necessity to include a functional assessment into the clinical evaluation as well as QoL measures. © TÜBİTAK. | |
dc.identifier.DOI-ID | 10.3906/sag-1106-12 | |
dc.identifier.issn | 13000144 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/17582 | |
dc.language.iso | English | |
dc.rights | All Open Access; Bronze Open Access | |
dc.subject | bronchodilating agent | |
dc.subject | steroid | |
dc.subject | adolescent | |
dc.subject | article | |
dc.subject | asthma | |
dc.subject | asthma control questionnaire | |
dc.subject | child | |
dc.subject | clinical article | |
dc.subject | correlation analysis | |
dc.subject | disease control | |
dc.subject | disease duration | |
dc.subject | disease severity | |
dc.subject | female | |
dc.subject | functional assessment | |
dc.subject | human | |
dc.subject | male | |
dc.subject | preschool child | |
dc.subject | quality of life | |
dc.subject | questionnaire | |
dc.subject | school child | |
dc.subject | Six Minute Walk Test | |
dc.title | Is the six-minute walk test correlated with disease control and quality of life in children with asthma? | |
dc.type | Article |